Tirzepatide, novel agent for treating type 2 diabetes has different efficacy in Asians and non-Asians: Study Medha Baranwal27 Feb 2024 1:00 AM ISTChina: A recent meta-analysis published in Diabetes Therapy has shed light on the comparative safety and efficacy of tirzepatide in Asians and...
Maternal Height Independent Risk of Adverse Outcomes in Women with Gestational Diabetes Dr Riya Dave21 Dec 2023 11:15 AM ISTA recent retrospective study conducted by Mengkai Du and colleagues from Zhejiang University in Hangzhou, China, shed light on a vital aspect of...
Body fat and nutrition strongly associated with diabetic kidney disease in type 2 diabetes patients: Study Medha Baranwal11 Dec 2023 12:00 PM ISTChina: A recent study published in Diabetes Therapy showed increased odds of diabetic kidney disease (DKD) in subjects with diabetes having poor...
SGLT2 inhibitor luseogliflozin bests DPP4 inhibitors among diabetes patients Medha Baranwal15 July 2023 10:30 AM ISTJapan: A recent study published in Diabetes Therapy has shown the efficacy of luseogliflozin (SGLT2 inhibitor) over DPP-4 inhibitors in the...
US FDA Guidance for Industry on Diabetes Therapies- Revisited Isra Zaman19 Jun 2023 1:12 PM ISTAmidst the continuous development of newer oral anti-diabetic agents, today we are going to revisit a significant guidance draft that was issued by...
Imeglimin lowers CVD risk by improving postprandial flow-mediated dilation among diabetes patients Dr Kartikeya Kohli6 Feb 2023 10:45 AM ISTCardiovascular disease (CVD) is the major cause of mortality in type 2 diabetes and high blood sugar, dyslipidemia, and hypertension are risk factors...
Increasing empagliflozin dose provides significant clinical benefits in type 2 diabetes: Study Medha Baranwal18 Aug 2022 7:30 PM ISTJapan: Switching from low-dose to high-dose SGLT2 inhibitor empagliflozin provides significant clinical benefits in patients with type 2 diabetes...
New recommendations for diabetic perioperative management Dr Monish Raut24 Jun 2022 8:00 PM ISTAccording to the National Diabetes Inpatient Audit (NaDIA), people with diabetes occupy around 18% of hospital beds. Diabetes patients are more...
DPP4 inhibitors reduce mortality risk in COVID-19 patients with diabetes: Study MD Editorial Team27 Oct 2021 9:00 AM ISTDiabetes is one of the most significant chronic diseases that increases the severity of COVID-19 and the associated risk of mortality in the pandemic....
Study Finds a Novel Pharmacodynamics of Sitagliptin MD Bureau5 March 2021 9:15 PM ISTIrisin is a unique myokine with striking effects on regulating insulin sensitivity and energy metabolism. In a recent study, researchers have found...
Diabetes therapy to cost 80% less savita thakur thakur22 Jan 2016 2:27 PM ISTA new drug based on the recently discovered molecule teneligliptin in the gliptin family is expected to bring down the cost of anti-diabetes therapy...
